The use of syntocinon in the management of excessive fluid absorption during endometrial ablation.
Five cases of intravenous oxytocin use during endometrial laser ablations complicated by excessive fluid absorption are reported. In each of the 5 cases it was possible to measure the rate of fluid absorption before and after the administration of this medication. There was a marked reduction in fluid absorption in 4 of the 5 cases, although the small number in the study did not allow statistical significance to be reached. The clinical benefit observed supports earlier work at this institution which suggests that oxytocic agents may be of value in cases of excessive fluid absorption through their action in contracting the myometrium and thereby compressing myometrial veins.
Shelley-Jones
D C
DC
Women's Endoscopic Laser Foundation, South Cleveland Hospital, Middlesbrough, United Kingdom.
Garry
R
R
Mooney
P
P
Kumar
C M
CM
Kokri
M
M
D000042:Absorption; D000328:Adult; D004717:Endometrium / Q000378:metabolism / Q000601:surgery*; D005260:Female; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control*; D053685:Laser Therapy / Q000009:adverse effects*; D008875:Middle Aged; D010121:Oxytocin / Q000627:therapeutic use*; D011446:Prospective Studies; D012965:Sodium Chloride / Q000008:administration & dosage / Q000493:pharmacokinetics
D012965:Sodium Chloride; D010121:Oxytocin